A research letter today in JAMA Network Open describes how nurses in Michigan may have reduced emergency department visits and hospitalizations of high-risk COVID-19 patients by coordinating at-home administration of neutralizing monoclonal antibodies (MABs) during the spring 2021 surge.From February to May 2021, three nurses at St.
Joseph Mercy Health System in Ann Arbor reviewed new positive COVID-19 test results and provider referrals from the system's hospitals to determine if patients were eligible for MAB administration under the Food and Drug Administration emergency use authorization (EUA).After the EUA, health systems struggled to implement MAB infusions because of difficulty with patient identification and enrollment,